Skip to main content
The BMJ logoLink to The BMJ
letter
. 1996 Nov 16;313(7067):1263. doi: 10.1136/bmj.313.7067.1263

Use of interferon beta 1b for multiple sclerosis. Patients will put up with side effects because of their desire to beat the disease.

M Chellingsworth
PMCID: PMC2352565  PMID: 8939140

Full text

PDF

Page 1263

1263

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Harvey P. Why interferon beta 1b was licensed is a mystery. BMJ. 1996 Aug 3;313(7052):297–298. doi: 10.1136/bmj.313.7052.297c. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES